AGP Executive Report
Last update: 11 minutes agoCancer Immunotherapy Breakthrough (Taiwan): NTUH researchers say they’ve found a way to “recharge” exhausted T cells in cancer patients using BET inhibitors, with animal results showing tumor suppression and longer survival; the work was published in Nature Immunology. Infectious Disease Watch (Taiwan): Taiwan CDC confirmed a Kaohsiung dengue cluster at Min-Sheng Hospital linked to an imported Vietnam case, with genetic matching and expanded testing of more than 1,400 people; no sign of wider community spread. New Case Alert (Taiwan): CDC also reported the youngest-ever Japanese encephalitis case: a 3-month-old infant in Hualien with no travel history, currently in intensive care, while the source of infection is still under investigation. Public Health Fraud Warning (Global): Uganda’s health ministry clarified travelers don’t need Ebola-free certificates, warning of fraudsters selling fake testing and documents. Wellness Industry (Regional): Malaysia’s Global Wellness Forum 2026 (June 23) will spotlight nutraceutical “format innovation,” with Taiwanese R&D teams expected to share product experience strategies. Biopharma Recognition (Taiwan): The 2026 Tang Prize in Biopharmaceutical Science went to pioneers of TIL and CAR-T cancer therapies, highlighting decades of patient-focused persistence.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
